Skip to main content
. 2018 Jun 18;13(6):e0199468. doi: 10.1371/journal.pone.0199468

Fig 2. Disease activity measures (ESR, CRP, 28TJC, 28SJC and DAS28-ESR) all improved in both groups over the 2 years of treatment with DMARDs.

Fig 2

Box plots for each disease activity measures at baseline, 1 year and 2 years after are displayed for each group (SNRA and SPRA). All the measures improved from baseline on both groups after treatment with DMARDs. DMARD: disease modifying antirheumatic drug, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, TJC: tender joint count, SJC: swollen joint count, DAS28-ESR: disease activity score 28 ESR.